ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Omacetaxine has been studied using cell lines (BCR-ABL- expressing myeloid and lymphoid) and in in vivo mouse model of CML and B-cell acute lymphoblastic leukemia bearing BCR-ABL or BCR-ABL-T3151 mutation.